| pubmed-article:8874341 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C0194037 | lld:lifeskim |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C0376152 | lld:lifeskim |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C1516698 | lld:lifeskim |
| pubmed-article:8874341 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:8874341 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:8874341 | pubmed:dateCreated | 1996-11-12 | lld:pubmed |
| pubmed-article:8874341 | pubmed:abstractText | To evaluate the following prospectively in poor-risk neuroblastoma (NBL) patients: (1) the feasibility and efficacy of in vivo purging of bone marrow; and (2) the outcome after autologous bone marrow transplantation (ABMT) when immunologically tumor-free, unpurged autografts were used. | lld:pubmed |
| pubmed-article:8874341 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8874341 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8874341 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8874341 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8874341 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:8874341 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:RapolaJJ | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:LanningMM | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:PerkkiöMM | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:SaarinenU MUM | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:HoviLL | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:WikströmSS | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:SariolaHH | lld:pubmed |
| pubmed-article:8874341 | pubmed:author | pubmed-author:MäkipernaaAA | lld:pubmed |
| pubmed-article:8874341 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8874341 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:8874341 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8874341 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8874341 | pubmed:pagination | 2791-802 | lld:pubmed |
| pubmed-article:8874341 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:meshHeading | pubmed-meshheading:8874341-... | lld:pubmed |
| pubmed-article:8874341 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8874341 | pubmed:articleTitle | In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation. | lld:pubmed |
| pubmed-article:8874341 | pubmed:affiliation | Division of Pediatric Hematology/Oncology, Children's Hospital, University of Helsinki, Finland. | lld:pubmed |
| pubmed-article:8874341 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8874341 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
